2022
DOI: 10.3389/fendo.2022.853765
|View full text |Cite
|
Sign up to set email alerts
|

The Implications of Bone Marrow Adipose Tissue on Inflammaging

Abstract: Once considered an inert filler of the bone cavity, bone marrow adipose tissue (BMAT) is now regarded as a metabolically active organ that plays versatile roles in endocrine function, hematopoiesis, bone homeostasis and metabolism, and, potentially, energy conservation. While the regulation of BMAT is inadequately understood, it is recognized as a unique and dynamic fat depot that is distinct from peripheral fat. As we age, bone marrow adipocytes (BMAds) accumulate throughout the bone marrow (BM) milieu to inf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
28
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(31 citation statements)
references
References 132 publications
2
28
0
1
Order By: Relevance
“…Our studies further suggest that the trabecular osteoblast's need for fatty acids is supported by PTH signaling in adipocytes. Bone-adipose interactions have been studied in several contexts as a result of the increase in bone marrow adiposity as bone mass decreases during the aging process (35,36) and the negative association between body mass index and bone mass (37)(38)(39). On the one hand, adipocytes produce adipokines, such as leptin and adiponectin, that suppress osteoblast function and lead to bone loss (40)(41)(42).…”
Section: Discussionmentioning
confidence: 99%
“…Our studies further suggest that the trabecular osteoblast's need for fatty acids is supported by PTH signaling in adipocytes. Bone-adipose interactions have been studied in several contexts as a result of the increase in bone marrow adiposity as bone mass decreases during the aging process (35,36) and the negative association between body mass index and bone mass (37)(38)(39). On the one hand, adipocytes produce adipokines, such as leptin and adiponectin, that suppress osteoblast function and lead to bone loss (40)(41)(42).…”
Section: Discussionmentioning
confidence: 99%
“…BMAds are important contributors to systemic adipokine levels ( 12 ), as well as regulators of bone ( 13 ) via RANKL expression ( 14 ) and hematopoiesis via stem cell factor (SCF) production ( 15 ), and have recently been implicated in bone metastatic cancers such as acute myeloid leukemia ( 16 ) and breast cancer ( 17 ). Interestingly, BM adipose tissue (BMAT) expands with aging and obesity ( 18 , 19 ), which are the two key risk factors for MM ( 20 22 ), suggesting that BMAds interact with and influence myeloma cells in the marrow. Indeed, adipocyte-derived factors such as monocyte chemoattractant protein 1 (MCP-1) and stromal cell-derived factor 1 (SDF1) are known chemotactic factors for myeloma cells ( 9 , 23 ), whereas other factors promote myeloma proliferation (e.g., leptin) ( 10 ) and resistance to chemotherapies (e.g., leptin and adipsin) ( 11 ).…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, BMSCs obtained from obese men exhibited enhanced adipocyte differentiation and accelerated senescence phenotype that would contribute to the skeletal fragility in obesity ( 71 ). T2D is another risk factor in skeletal fragility and osteoporosis in aging men and postmenopausal women ( 128 130 ), despite the increase in BMD or independent of BMD ( 131 , 132 ). The combination of obesity and T2D were shown to exhibit higher serum insulin levels and BMA at the lumbar spine and femoral metaphysis compared to the subjects without T2D.…”
Section: Obesity and Diabetesmentioning
confidence: 99%